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Underappreciation of Endothelial Glycocalyx
Morgan Potts, BSN, RN, CCRN
Otterbein University, Westerville, Ohio
Introduction
While most clinicians have a
basic understanding of the
human body’s “pumps and
pipes,” many do not know that
blood vessels contain a special
protective layer called the
endothelial glycocalyx. Its
unique composition and
function make it important to
more than several
pathophysiologic processes in
the body.
When the endothelial
glycocalyx is damaged, the
luminal side of the
endothelium is no longer
protected and complications
can occur. There are four main
identifiable reasons that
contribute to the degradation
of the glycocalyx and
surprisingly, all are very
common among those who are
critically ill.
This structure is worth
discussing because it
ultimately dictates the
severity of hemodynamic
compromise that can occur
once the glycocalyx is
degraded. By avoiding
damage, the hope is that both
morbidity and mortality can
be reduced.

Pathophysiologic Process
Composition:

How It Helps:

The endothelial glycocalyx is a
slimy, gel-like substance in the
shape of thin, hair-like
projections on the inside of the
lumen wall in blood vessels (see

• Regulates vascular
permeability by acting as a
double barrier to large and
small molecules

figure 1).

• Regulates vascular tone

It is primarily made up of
glycoproteins and proteoglycans.
Glycoproteins are proteins that
have carbohydrate groups
attached to a polypeptide chain
while proteoglycans are proteins
bonded to glycosaminoglycan
groups. Without plasma
constituents binding to the
glycocalyx such as albumin, the
glycocalyx has no active
physiologic role.
Once the structure binds
plasma constituents, like albumin
to its surface, they together form
the active endothelial surface
layer. The surface has a net
negative charge and repels other
negatively charged molecules as
well as red and white blood cells
along with platelets (Alphonsus
& Rodseth, 2014).

• Protects endothelial cells
from shear stress
• Prevents adhesion of white
blood cells and platelets to
vessel wall

Damaged Endothelial Glycocalyx Worsens
Patient Outcomes
Signs and symptoms of a
damaged glycocalyx include:
•

Capillary leak

•

Edema

•

Increased inflammation

•

Platelet aggregation

•

Hypercoagulability

•

Loss of vascular tone
(Biddle, 2014)

Lab data that shows an
elevation in serum glycocalyx
shedding positively correlates
with a worsened clinical
outcome in critical illness
(Colbert & Schmidt, 2016).
When the glycocalyx is
damaged, parts of the
structure are broken down
and the flow of blood releases
these parts into circulation(see
figure 2).

Figure 2. Microscopy before and after ischemia has damaged the glycocalyx .
Source: (Biddle, 2014)

• Docks coagulation
enzymes creating
antithrombotic effect in
vasculature
• Allows red blood cells to
flow smoothly through
vessel (Biddle, 2014)

Figure 1. Microscopy of vessel lumen with enlargement of glycocalyx. Source:
(Roberson & Watton, 2013)

Lab Testing & Treatment
Using glycocalyx degradation
as a marker for severity of
endothelial damage and/or
critical illness may be a potential
laboratory value of merit. It may
also be a new screening tool for
sepsis (Martin, Koczera,
Zechendorf, & Schuerholz, 2016).
Currently, there is not enough
research to demonstrate its
routine use. Point-of-care testing
may be worth further research.

Microcirculation-protective
therapies like steroids, colloids,
vasopressors, and anticoagulants
were initially thought to protect
the glycocalyx, however,
outcomes in clinical trials have
shown no therapeutic benefit
(Colbert & Schmidt, 2016).
Currently, there are no
recommended treatments other
than treating the underlying
cause.

Main Culprits
Ischemia

Hypervolemia

Without oxygen, the
glycocalyx begins to degrade
and shed its full, thick coat.
The vessels that supply blood
to the heart as well as the
vessels that supply blood to
the central nervous system are
particularly more sensitive to
ischemia (see figure 2). Once
shedding starts, leukocyte and
platelet adhesion to the
epithelial surface exacerbates
the injury (Biddle, 2014).
Higher concentrations of
serum glycocalyx components
have been noted particularly
in peripheral arterial surgery
and coronary artery bypass
surgery (Alphonsus & Rodseth,
2014).

By administering too much
IV fluid, preload of the heart
increases. As the right atria
and left ventricle begin to
stretch, natriuretic peptides
are released and activate
metalloproteinases that digest
the glycocalyx. This is
especially true if the IV fluid is
albumin and the patient is
normovolemic prior to the
infusion since albumin is made
up of larger molecules and
stays in the intravascular
space longer (Chappell &
Jacob, 2014; O’Connor &
Prowle, 2015)

Inflammation

Hyperglycemia

Inflammatory mediators,
such as cytokines, in trauma
and septic patients degrade the
glycocalyx. The cleavage of the
glycocalyx renders the
endothelium bare; this
contributes to capillary leakage
(Chen, 2016a). Also, shearing
stress to the endothelium
causes release of nitric oxide
which in turn causes
vasodilation of blood vessels.
This is one reason why septic
patients are profoundly
hypotensive in addition to the
hypovolemia caused by fluid
leaking out into the interstitial
space. Serum levels of
glycocalyx degradation in
septic patients are correlated
with worse outcomes (Chen,
2016b).

Elevated blood glucose,
especially in type-1 diabetic
patients, degrades the
glycocalyx. Research has
shown that type-1 diabetics
have half the thickness of a
normal glycocalyx when
compared to non-diabetic
counterparts (Alphonsus &
Rodseth, 2014). Even in
healthy, non-diabetics, 6 hours
of hyperglycemia degrades the
systemic glycocalyx by 50%
(Biddle, 2014).

Implications
Despite the lack of
treatment options to reduce
the severity of damaged
endothelial glycocalyx,
understanding its purpose
and the negative
consequences it can have will
allow clinicians to avoid
exposing their patients to the
main culprits of degradation.
Future research should be
focused on point-of-care lab
testing and effective
microcirculation-protective
therapies.

Conclusion
The glycocalyx is an
underappreciated component
of the endothelial vascular
layer that resides within the
lumen of blood vessels. Due to
its sensitive nature, every
effort to protect its structure
should be utilized.
By avoiding ischemia,
hypervolemia, inflammation,
and hyperglycemia, the risk of
capillary leak, edema, and
other complications can be
avoided. Analyzing the
microcirculation is a
promising new way to detect
early dysfunction and
improve the outcomes for
those who are critically ill.

